by Marina Chenery | May 20, 2021 | General, Publications and presentations
This Open Access paper outlines practical applications of deep imputation on large-scale drug discovery data. It compares deep learning to traditional QSAR methods. Find out more about deep imputation by visiting our Cerella webpage. Summary Accurately predicting...
by Marina Chenery | May 20, 2021 | News
Optibrium and BioPharmics Enter Partnership on Computational Drug Design Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. CAMBRIDGE, UK, 20 May 2021 –...
by Marina Chenery | May 11, 2021 | Webinars
eSim3D: Electrostatic-Field and Surface-Shape Similarity for Ligand-Based Drug Design This webinar was presented by Ajay N. Jain and Matt Segall. In this webinar, we present eSim3D, a novel ligand-based drug design approach based on electrostatic-field and...